Tag: Cancer: Bladder
Younger Age at Menopause Tied to Higher Risk for Bladder Cancer
Women with menopause onset by age 45 at higher risk than those with onset at age 50 or older
Smoking Associated With Worse Bladder Cancer Outcomes
Smokers had poorer response to cisplatin-based neoadjuvant chemotherapy, higher recurrence risk
Noninvasive Diagnostic Imaging Accurately IDs Bladder Cancer
Method evaluating cells collected from urine shows 94 percent diagnostic accuracy
Treatment Tied to Survival Benefit in Complex Bladder Cancer
Medically complex patients with superficial disease have reduced deaths with treatment vs. observation
Gender Difference in Survival Seen After Radical Cystectomy
Females have worse disease-free, cancer-specific, overall survival versus males with bladder cancer
PPD Skin Test Enhances Bacillus Calmette-Guérin Tx in Bladder CA
Enhanced therapeutic effect of bacillus Calmette-Guérin tx in non-muscle invasive bladder cancer
Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence
Immediate post-resection gemcitabine reduces recurrence over 4 years in low-grade bladder cancer
Non-Invasive Test Can Detect Urothelial Cancer
When combined with cytology, UroSEEK detected 95 percent of patients who developed bladder cancer
Prognostic Model Developed for Immunotx of Urothelial Cancer
Model, based on six factors, predicts overall survival for patients treated with atezolizumab
Active Surveillance OK for Non-Muscle Invasive Bladder Cancer
Appears to be a cost-effective strategy for patients with small size, stage pTa or pT1a recurrent tumors
